The critical role of TGF-β-mediating Smad (mainly Smad3) signaling has been demonstrated in EMT associated with PM2.5 stimulation, bleomycin challenge, and tumour progression/development [18, 19, 64–69]. The gene discussed is TGFB1; the disease is neoplasm.